Effect of digoxin on A-V conduction

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Patients with pre-existing conduction system disease are susceptible to atrioventricular (A-V) block.
• Digoxin is a cardiac glycoside commonly used for heart failure and arrhythmias, but its effects on diseased conduction tissue require careful consideration.

Purpose of the Study:

• To investigate the electrophysiological effects of digoxin on A-V conduction in patients with known conduction system disease.
• To determine if digoxin can precipitate or worsen heart block in patients with transient or chronic A-V block.

Main Methods:

• Studied 19 patients with established conduction system disease (15 with transient complete heart block post-myocardial infarction, 4 with chronic intermittent complete heart block).
• Patients were monitored with demand pacing systems and studied upon return to sinus rhythm.
• Assessed the impact of therapeutic and high serum levels of digoxin over seven days.

Main Results:

• Digoxin administration did not precipitate a return to second- or third-degree heart block in any patient.
• The duration of complete heart block following myocardial infarction was slightly longer in patients taking digoxin during the block (4.3 days) compared to those starting digoxin after sinus rhythm returned (3.3 days).

Conclusions:

• In patients with known conduction system disease, therapeutic levels of digoxin do not appear to induce or worsen atrioventricular block.
• Further research may be warranted to fully elucidate the nuanced effects of digoxin in specific patient populations with conduction abnormalities.